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Tick – borne relapsing fever (TBRF) is globally dispersed, and within the United States is 
found primarily in the mid – west, south - west, and north – west portions of the country. 
TBRF is a disease which causes patients to experience flu – like symptoms and is 
distinguished by multiple relapses of high fever which can cause individuals to be 
hospitalized multiple times over months. TBRF is caused by Borrelia spp. spirochetes 
and spread by Onthidoros spp. soft – shelled ticks.  First diagnosed in the early 20th 
century, the disease has gone underdiagnosed and has attracted little attention for over a 
century despite being the cause of illness in multiple outbreaks. Previous reviews on the 
subject have been limited in scope and focused on state – specific reports in localized 
regions of the country. The primary and secondary objectives of our review were to 
describe the epidemiology, scope, and clinical outcomes of TBRF to update the medical 
community on its impact and also to establish an evidence - based reasoning for inclusion 
of TBRF in the NNDSS. We present our review of TBRF as the most expansive in regard 
to years covered and sample size. As well, this is the only review, to our knowledge, 
which has collected and analyzed data by infection type. Papers selected for review had 
to be original case reports of TBRF infections, published in English, and have occurred in 
the United States. Data from similar reviews were not included nor were those papers 
used for analysis. Added criteria were used to collect data on cases which could be used 
for logistic and Poisson regressions analyzing the likelihood of clinical outcomes. After
vi 
 the review process was complete, 80 papers were used for the primary analysis and 40 
papers used to collect data for regression analyses. Results showed that most of TBRF 
infections took place in adults and children. Men were statistically more likely to be 
infected than women (p= <0.0001). Symptom profiles for causative agents confirmed flu-
like symptoms as the most reported (headaches, vomiting, chills/sweats) but revealed that 
many symptoms were statistically more likely to be found in B. turicatae infections 
compared to B. hermsii infections, indicating that infection type influences clinical 
presentation of the disease. Modeling febrile episodes and Jarisch – Herxheimer reactions 
on treatment type hinted that some treatments are better than others but no statistically 
significant claims can be drawn from this analysis. In conclusion, this review highlights 
important differences between our results and prior published literature reviews, as well 
as provides recommendations on reporting practices, treatment protocols, and future work 
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The National Notifiable Diseases Surveillance System (NNDSS) is a network of systems 
run by the United States Centers for Disease Control (CDC) and Prevention which works 
on a national level to compile data on disease incidence, distribution, disease agents, and 
host factors. The NNDSS works in conjunction with the Council of State and Territorial 
Epidemiologists (CSTE), whose job it is to provide a recommended list of nationally 
notifiable diseases and coordinate with state and local health departments and health 
agencies, which provide case data for informing periodical updates to the list of 
nationally notifiable diseases.1   
Disease reporting begins on the state and local level with cases identified by 
health providers, hospitals, and laboratories. State legislatures, on recommendation from 
health agencies and health professionals, dictate which diseases are mandatorily reported 
allowing for state funds to be utilized accordingly.2 There are many diseases which are 
universally reported, such as salmonella outbreaks and highly contagious vaccine-
preventable infectious diseases. Other diseases, which are found regionally, are 
sporadically reported depending on the incidence of disease. Because there are no federal 
laws which dictate disease reporting, conveying information to the CDC on the federal 
level is technically voluntary. Despite being non-compulsory, every U.S. state health 
department, five territorial health departments, and two local health departments (New 
York City and D.C.) report to the CDC for diseases which are nationally 
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notifiable.3 Diseases on the nationally notifiable list are those of particular concern for 
public health, thus justifying allocation of state tax revenue and health department 
resources for tackling of these priority conditions. This criterion includes emerging 
pathogens or any other disease which is deemed a large enough health concern. If 
properly addressed, the incidence of these diseases and health hazards are reduced, and if 
at some point the incidence is reduced enough or its surveillance is not seen as justifiably 
beneficial, a disease may be taken off the notifiable list. Some of the benefits of having a 
disease on the nationally notifiable list is that it receives more exposure to the health 
community and local resources, making identification and treatment easier and more 
efficient. Further, it helps establish and/or create a federal database on all reported cases 
in the United States.4–6 Additionally, the infrastructure created by surveillance reporting 
laws ensures the maintenance of strong working relationships between physicians and 
public health entities that are critical for effective infectious disease outbreak response.7 
Centralized and formatted data is incredibly useful for conducting research on diseases 
and coming up with strategies to prevent further incidence. One of the diseases not 
currently on the nationally notifiable list is Tick – borne Relapsing Fever (TBRF).    
Relapsing fever is a global vector-borne disease caused by infection with Borrelia 
spp. spirochetes. Louse and tick – borne relapsing fevers are epidemic and endemic, 
respectively.8,9  While the primary foci of louse-borne relapsing fever is east Africa, a 
true understanding of TBRF is less known yet of public health importance, and early 
identification of endemic areas can prevent future outbreaks.10,11 Global estimates of 
TBRF are lacking, but the disease has been reported in Africa, Asia, Europe, and North 
America.12 In Asia, specifically in Japan, various Ixodes ticks are responsible for 
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infection with Borriella miyamatoi spirochetes,13 whereas in Africa, several Ornthidoros 
spp. soft ticks, such as Ornthidoros moubata, transmit Borrelia duttoni, B. crocidurae, 
and B. hispanica.12,14 Our understanding of endemic TBRF in the United States is still in 
its infancy with only two major reviews done on the disease, both published in the last 15 
years.15,16     
In the United States, TBRF is most commonly found in the south-west, mid-west, 
and pacific north-west, with California and Colorado being the biggest contributors to 
disease incidence.16 TBRF, as the name suggests, is a disease which causes intermittent 
febrile episodes and is contracted after a tick vector has taken a blood meal from a human 
host. Those infected can expect, on average, to experience two to four febrile episodes 
with fevers ranging from 103 degrees to 108 degrees Fahrenheit. Pregnant women are 
particularly vulnerable to TBRF and can experience spontaneous miscarriage, hepatic 
involvement, neonatal asphyxia, preterm delivery, and death. Transmission of the 
spirochete from mother to infant can occur prenatally via the placenta or during labor and 
birth.17 Less serious complications caused by TBRF include chills/sweats, nausea, 
malaise, and headaches. Standard treatment varies from single to multiple rounds of 
antibiotics including tetracycline, doxycycline, and macrolides (e.g. erythromycin). 
Patients treated with antibiotics for TBRF have a 50% chance of experiencing a Jarisch – 
Herxheimer reaction where their symptoms worsen along with rigors, hypotension, and 
high fever.15 TBRF has been treated with many different types of antibiotics in the past 
and present, most likely due to the lack of treatment guidelines for TBRF which would 
standardize treatment protocols for the disease.18   
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The causative agents of TBRF are bacterial spirochetes of the genus Borrelia and 
species in the United States are B. hermsii, and B. turicatae. Similar to other spirochetes, 
B. hermsii and B. turicatae bacteria manipulate surface antigens to avoid detection from 
host defenses.18–20 This ability to change surface proteins lets them hide out in hosts and 
cause bouts of high-grade fever when proliferation of the bacteria becomes high enough. 
The spirochete (corkscrew) shaped bacteria are problematic for diagnosis using 
microscopy because their shape is similar to other bacteria such as Helicobacter, for 
example.18 Serological testing also presents some challenges because false positives on 
tests for Lyme disease are common due to the similarity of proteins between the Borrelia 
spp.21–23 Knowing the geographic region the patient was exposed along with other 
contextual pieces of clinical and epidemiological information is important for proper 
identification, diagnosis, and treatment.  
The ticks which bear these bacteria are argasid (soft-bodied) ticks of the genus 
Ornithodoros. In the United States, the bacteria species are named for the tick which 
bears them. O. hermsi ticks are typically found in high elevation areas (>5000ft) along 
the Western US mountain ranges whereas O. turicata ticks are found in low elevation 
areas such as Texas, Florida, and Nevada.16 Sylvatic transmission occurs during 
bloodmeal feeding between ticks and reservoir species, primarily squirrels, chipmunks, 
and other rodents. Humans are not typical reservoir hosts but can be infected and serve as 
competent mammalian reservoirs if bloodmeals are taken during the febrile bacteremia 
period. Spirochetes are transmitted via tick saliva, and once in the human blood stream 
they begin to proliferate in the human host causing disease.24 Vector characteristics play 
an important role in transmission. To illustrate this, compare the differences between 
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Ixodidae (hard) and Argasidae (soft) bodied ticks. Besides having different physical 
appearances, the ticks also have different life cycles and feeding strategies.25 Hard ticks 
have only three life stages, a larval stage, a nymphal stage, and an adult stage whereas 
soft ticks have several nymphal stages as well as the larval and adult stage. The increased 
number of nymphal stages translates to greater pathogen transmission opportunities as 
soft ticks require bloodmeal to complete each molting.26 Hard ticks seek out prey and are 
active during daylight and nighttime hours while soft ticks lie in wait for their prey and 
are primarily nocturnal. Lastly, feeding time for hard ticks is much longer (hours to 
weeks) than soft ticks (15 – 90 minutes).25  
Hard ticks are responsible for transmitting Lyme disease, Rocky Mountain 
spotted fever, tularemia, Colorado tick fever, etc. while soft ticks are known only to 
transmit TBRF.27,28 This may be in part to the types of hosts the ticks feed on and the 
ubiquity with which hard ticks are found allowing them to come into contact with a larger 
variety of species. Their predator habits, seeking out their prey, add to this fact but also 
show why people are more likely to come into contact with hard ticks. Soft ticks come 
into contact with human hosts most commonly in remote caves, cabins, or camping sites, 
and because they feed at night, they are less active than hard ticks.  
While hard ticks are responsible for most of the disease burden caused by tick 
species, however, there are two characteristics of soft ticks which makes them especially 
worth considering as a public health issue. Unlike the hard tick which can only transmit 
the spirochete bacteria during its adult life state, soft ticks can pass on the bacteria 
throughout all nymphal stages as well as their adult stage. While more limited in activity 
than hard ticks, they are more dangerous over their lifespans respectively because they 
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can transmit the bacteria earlier than hard ticks and for a longer period of time. Soft ticks 
not only feed for a shorter period of time, their time to transmit the bacteria is also much 
shorter than the hard ticks. Soft ticks have been shown to transmit spirochetes within 30 
seconds, much less than the hours it takes a hard tick to transmit a pathogen like the one 
that causes Lyme disease.29 If a person is bitten by a tick which carries B. burgdorfi, there 
is a good chance that individual will not be infected as long as they notice the tick 
feeding within an hour or two.30 Yet, if an individual is fed on by an O. hemsi tick, the 
time it takes to notice the tick feeding is almost inconsequential as it is likely long passed 
the time necessary to transmit the bacteria. Lastly, Ornithodoros spp. ticks can live up to 
10-20 years and go years without a bloodmeal source, which is significantly longer on 
both accords than its hard tick comparator.    
TBRF is often overshadowed by other louse/tick borne infections because it 
accounts for less of the disease burden in this category than other diseases. Between 1990 
and 2011 there were only 504 cases of TBRF reported to state and local agencies.16 For 
comparison, over 30,000 cases of Lyme disease are reported to the CDC every year with 
estimates that the true burden of disease is between 296,000–376,000 cases/year.31,32 But 
incidence alone does not tell the whole story. Because there is no national reporting 
recommendation for TBRF, it is likely that the amount of cases reported is much lower 
than the actual burden. Difficulty in identifying the causative agent with microscopy and 
laboratory techniques might also be a contributing factor to underreporting. Those who 
become infected by TBRF experience reoccurring episodes of debilitating fevers, 
headaches, and pains. In more extreme cases TBRF can cause death, especially in 
childbearing mothers and neonatal infants. Overall disease burden might not be high, but 
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morbidity associated with TBRF is extreme. TBRF is an easily acquired, dangerous 
infection which requires more attention. Making TBRF a nationally notifiable condition, 
along with constructing standardized treatment guidelines will help prevent future cases 
of the disease, decrease mortality, and mitigate morbidity.  
Despite a suspected knowledge gap among United States physicians, cases have 
been consistently reported since 1922.9,15 The primary goal of this historical review is to 
inform the medical community of TBRF clinical characteristics and epidemiologic 
associations in an effort to identify areas of high disease burden and enhance differential 
diagnosis of high-risk populations. We theorize that the lack of notifiable disease status 
has resulted in low knowledge among healthcare providers possibly translating to an 
underdiagnosis of these important pathogens. The secondary aim is to compare the 
Borrelia species responsible for TBRF to identify potential differences in infection 
prevalence, clinical manifestation of disease, transmission of risk factors, risk of Jarisch-
Herxheimer reaction and mortality rate. The last aim of this paper is to use the 
information gathered in the systematic review to determine a potential need, rational and 







A systematic review was conducted in compliance with Preferred reporting items for 
systematic reviews and meta-analyses (PRISMA).33 Our initial literature search was 
conducted utilizing Medline and PubMed using the following search terms: tick borne 
relapsing fever, Borrelia turicatae, Ornithodoros turicata, Borrelia hermsii, 
Ornithodoros hermsi, and United States. Ornthidoros parkeri and Borrelia parkerii were 
excluded from this review, as they were only added to the list of TBRF causative agents 
within the last three years and would not have adequate representation in our historical 
review. In an effort to include all historical manuscripts that might not be included in 
current electronic format, a second trace-back search of included manuscripts’ reference 
lists was also conducted. Manuscripts were excluded if transmission was suspected 
outside the geographic United States, not published in English, or if the article was not 
clinical or human health related. In order to gather sufficient sample sizes and maintain 
data quality, information from each article was screened on the basis of each variable. If a 
paper included an appropriate amount of data concerning method or place of infection, 
duration of sickness, and risk factors then it was included in the analysis. For example, if 
a paper reported infections on 100 patients but only had symptom data for two then only 
the symptom data for those two cases would be analyzed while the other 98 would be 
discounted from inclusion in a denominator on symptom frequency so as to avoid zero 





guiding principle in this exercise was to make sure that the total number for the article 
had corresponding, matching data on the variable which statistics were gathered on. The 
second literature collection, a sub grouping of the original, was gathered in order to 
perform a regression analyses on two clinical outcomes as well as descriptive statistics on 
infection characteristics. The added criteria for inclusion in this collection required that 
the data be matched to a particular ID. Whereas the larger dataset included aggregate and 
specific data, the smaller dataset only included data which had matching participants. To 
be matching, data on prognosis, symptoms, treatment, and risk factors must be related to 
an identified patient with information on age and sex available.  
Information extracted from each article included clinical history and presenting 
illness, clinical laboratory values, diagnostic test used, patient prognosis and course of 
illness, and epidemiologic risk factors. Descriptive statistics summarized each of these 
categories’ variables. Chi-squared tests were used to test for independence between 
proportions of individuals with B. hermsii or B. turicatae infections on the basis of sex, 
age, and symptom frequency. In instances with small frequency counts (≤5), Fisher’s 
exact test was used in place of a Chi-squared test. Disease prognosis by infection type, 
including average incubation days, average febrile and afebrile days, and average number 
of febrile episodes was analyzed via a T-test under normal theory assumptions. In 
addition to these analyses, a multivariable logistic model was used to estimate the risk of 
a Jarisch – Herxheimer reaction using treatment comparisons as the predictor of interest 
with standard statistical assumptions. Poisson regression was used to analyze the 
association between number of febrile episodes and treatment type and other standard 





were performed using SAS 9.4 software (SAS Institute Inc., Cary, North Carolina). 
Finally, geospatial cluster analysis was performed on cumulative clinical records by 








The original literature search and subsequent search done by reviewing sources included 
in the first search yielded 190 articles. After screening by titles and abstracts, three were 
found to contain duplicate data and removed from the review. 187 articles were screened 
through full text and 111 were excluded leaving 76 papers for the primary analysis. Of 
those 76, 40 met the requirements for inclusion in the secondary analysis and were 
included therein (Figure 3.1).  
Primary Analysis Findings 
The total number of cases included was 1241 (B. hermsii = 493 | B. turicatae = 748), 
ranging in years from 1915 to 2016. Both B. hermsii and B. turicatae infections occurred 
primarily in adults and children. Combining both age categories, adults and children 
accounted for 95% of B. hermsii infections and 99% B. turicatae infections. Age data 
was analyzed categorically. Four discrete age groups were constructed (adult ≥ 18 years, 
pediatric 1 – 17 years, infant < 1 year, elderly ≥ 60 years). There were no significant 
differences in the proportion of infections comparing all age groups (p=0.4288), nor were 
there significant differences in proportions of infections comparing adults to children 





of males with B. hermsii or B. turicatae infections was significantly higher (p= <0.0001) 
than females (Table 3.1).   
Aggregated symptom data was available for 433 patients (B. hermsii = 391 | B. 
turicatae = 42). Fever, chills/sweats, headache, nausea, vomiting, myalgia, weakness, and 
malaise were the most reported symptoms among both infections combined, with each 
being reported 18% – 77% of the time. Clinical symptoms were recorded dichotomously, 
even if symptoms reoccurred during multiple relapses. Symptoms indicative of serious 
complications, including splenic enlargement and tachycardia were reported for 
combined infections 13% and 8% of the time. Other serious complications, including 
tachypnea, jaundice, hypoxia and syncope were reported less than 5% of the time. There 
were statistically significant differences between infection types for most of the 
symptoms (symptoms reported >5% of the time). Compared to B. hermsii, those infected 
with B. turicatae were more likely to report fever (p=0.0012), headache (p=0.0007), 
nausea (<0.0001), vomiting (p=0.0004), myalgia (p=0.0365), weakness (p=0.0004), 
arthralgia (p=0.0012), malaise (p=<0.0001), rash (p=<0.0001), tachycardia (p=<0.0001), 
and back pain (p=<0.0001) (Table 3.2). Conversely, B. hermsii patients were more likely 
to present with anorexia (p=0.0071) than B. turicatae patients. 
Aggregated data for other prognostic indicators including incubation period, 
febrile days (how many days total experiencing fever), afebrile days (how many days 
total without fever between febrile periods), and total febrile episodes (instance of a 
febrile period or episode) was collected for 929 patients. Overall, the average amount of 





4 febrile days and 4 febrile periods and 7 afebrile days. No significant differences 
between infection types were noted for each of these variables (Table 3.3). 
Published reports on year of incidence was available for 1241 patients. The 
primary dataset found that most case data were for infections which occurred in the early 
to mid – 20th century, specifically in the 1930s and 1960s. Some of that data that was 
collected was on a range of years. For those infections the midpoint in the range of years 
was selected as year of infection (Figure 3.2). Data on month when infection occurred 
was collected for 1485 patients. Most cases take place in the summer months and trails 
off in the fall and winter while gradually increasing through the spring. The months of 
June, July, and August are roughly responsible for a combined 60% of the total incidence 
observed in the study (Figure 3.3). Incidence by state where infection was either 
confirmed or suspected to have occurred was included for 1110 people in 14 states. Over 
50% of these cases took place in Texas which means that the causative agent in these 
TBRF infections was most likely B. turicatae. This is in contrast to recent literature 
which typically sties cases in California and Colorado as having the highest incidence for 
TBRF. California and Colorado were the next highest states for TBRF infections, besides 
Arizona, with 619 and 63 cases each, respectively. A single case was noted in Ohio, far 
from the endemic areas where Ornthidoros spp. ticks are typically found (Figure 3.4).  
Secondary Analysis Findings 
The following are the findings presented from the case files with matching data. The total 
number of cases included in this analysis was 67 (B. hermsii = 51 | B. turicatae = 16) 





67 cases. Only 25% of patients reported observing a tick bite and evidence of tick 
infestation was found in only 22% of cases. Most infections occurred in either cabins 
(34%), caves (17%), and the general outdoors (8%). Borellia positive ticks and Borellia 
positive reservoir animals were located at the site of infection 18% and 13% of the time, 
respectively. In almost half of all cases (41%), the sleeping structure where infection 
occurred was uninhabited at times, often for months (Table 3.4).   
Using case specific data collected in the secondary analysis, two regressions were 
generated to describe possible relationships between treatment type and either risk of 
Jarisch – Herxheimer reactions or number of febrile episodes. The first outcome was 
analyzed using a logistic regression with age and sex as co-predictors along with 
treatment type. In current literature, tetracycline is often cited as the preferred treatment 
for TBRF, thus in our analysis tetracycline was used as the referent group comparing 
doxycycline, penicillin, or combination/other treatments. Odds ratios show that penicillin 
and combination/other treatment was less likely (OR = 0.90 and 0.66, respectively) than 
tetracycline alone to result in a Jarisch – Herxheimer reaction. However, doxycycline was 
2.56 times as likely to result in a Jarisch – Herxheimer reaction than tetracycline (Table 
3.5).  
To evaluate the association between treatment type and number of febrile 
episodes, a Poisson regression was used. Compared to tetracycline treatment, the 
incidence rate ratios for number of febrile episodes were 1.24, 1.11, and 0.79 for 
combination/other, doxycycline, and penicillin, respectively. This means that the incident 
rate of febrile episodes for combination/other treatment was 1.24 times the incident rate 





lower incident rate of febrile episodes compared to tetracycline use (Table 3.6). Note that 
the results of the logistic and Poisson regressions are not statistically significant, as the 
inferences associated with the outputs have wide confidence intervals that include one, 
indicating the possibility that there were no differences in either measured outcome based 





Figure 3.1 Flowchart displaying search process and 
















Table 3.1 Demographic characteristics of TBRF cases. 
Variable B. hermsii (N=308) B. turicatae (N=100) p-value 
Age (%)   0.4288 
  Adult (18-60) 126 (56) 55 (65)  
  Pediatric (1-17) 86 (39) 29 (34)  
  Infant (<1 yr) 5 (2) 0 (0)  
  Elderly (60+yrs) 6 (3) 1 (1)  
Sex (%)   <.0001 
  Male 194 (63) 259 (87)  
  Female 114 (37) 40 (13)  



















Table 3.2 Symptom profile of TBRF cases.    
Symptom Overall N (%) 
N = 433 
B. hermsii n (%) 
n = 391 
B. turicatae n (%) 
n = 42 
 p-value 
Fever 337 (77) 296 (76) 41 (98)   0.0012 
Chills/Sweats 212 (50) 193 (49) 25 (60)   0.2106 
Headache  223 (53) 200 (51) 33 (79)   0.0007 
Nausea 148 (35) 122 (31) 26 (62) <0.0001 
Vomiting  132 (32) 118 (30) 24 (57)   0.0004 
Myalgia 202 (48) 185 (47) 27 (64)   0.0365 
Weakness 93 (22) 75 (19) 18 (43)   0.0004 
Arthralgia 46 (11) 43 (11) 12 (29)   0.0012 
Anorexia 69 (16) 67 (17) 1 (2)   0.0071 
Malaise 78 (18) 55 (14) 23 (55) <0.0001 
Abdominal Pain 44 (10) 51 (13) 0 (0) NA 
Rash  42 (10) 21 (5) 23 (55) <0.0001 
Splenic Enlargement 57 (13) 50 (13) 7 (17)   0.4799 
Tachycardia 35 (8) 21 (5) 14 (33) <0.0001 
Eye pain 34 (8) 34 (9) 0 (0) NA 
Back pain 33 (8) 8 (2) 25 (60) <0.0001 
Red eyes 33 (8) 33 (8) 0 (0) NA 
Diarrhea 26 (6) 26 (7) 0 (0) NA 
Note. Rest of symptoms including blurred vision, congestion, confusion, 
dehydration, dizziness, dyspnea, epigastric pain, fatigue, hypotension, 
hypoxia, jaundice, lethargy, leg pain, meningitis (suspected), photophobia, 
retrobulbar pain, rhinorrhea, sore throat, syncope, tachypnea, and weight 
loss each accounted for ≤ 5% of symptom occurrence. 
 
 











Figure 3.2 Incidence of infections described over the decades.  
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Table 3.3 Prognostic indicators of RF by causative agent.  
 Overall avg. (range) B. hermsii avg. 
(range) 






9 (1-25) 8 (1-15) 10 (6-25) 0.588 
Febrile 
Days 
4 (1-17) 4 (1-17) 4 (1-9) 0.978 
Afebrile 
Days 
7 (1-20) 7 (1-20) 8 (5-10) 0.446 
Febrile 
Episodes 





























Figure 3.3 Incidence of infections by month.   
 
Figure 3.4 Shaded map of confirmed or suspected TBRF 
cases identified in the final analysis.  
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Table 3.4 Characteristics of infection. 
Characteristic % cases reported  
Patient reported tick bite 25% 
Cabin associated  34% 
Trailer Associated 1% 
Camping Associated  4% 
Evidence of tick infestation  22% 
Ticks recovered from site 21% 
Cave site 17% 
Condominium 4% 
General outdoors  8% 
B+ ticks found at site 18% 
B+ animals found at site 13% 
Pregnancy associated  5% 





Table 3.5 Results of logistic regression modeling Jarisch - Herxheimer reaction and 
treatment comparison.  
Treatment Comparison Estimate OR (95% CI) 
Combination/other vs. Tetracycline -0.5218 0.66 (0.048 – 9.03) 
Doxycycline vs. Tetracycline  0.8387 2.56 (0.173 – 38.4) 
Penicillin vs. Tetracycline  -0.2096 0.90 (0.044 – 18.5) 
Note. Confidence intervals calculated with alpha at 0.05. 
 
 
Table 3.6 Results of Poisson logistic regression modeling number of febrile episodes 
and treatment type.  
Treatment  Estimate IRR (95% CI) 
Combination/other  0.212 1.237 (0.736 – 2.076) 
Doxycycline  0.111 1.117 (0.574 – 2.175) 
Penicillin   -0.239 0.788 (0.358 – 1.735) 
Note. Confidence intervals calculated with alpha at 0.05. Treatment tetracycline used 




















This review reports on TBRF clinical epidemiology based upon published reports 
spreading over a century cumulating 1200 cases originating from 14 states. The 
methodology of this report, unlike similar published reviews which use state reported 
data, uses previously published cases. This methodological difference can result in less 
precise measurements but one of the advantages of our approach is an increased amount 
of information over more years which shows not only a current report on the state of the 
disease but also a historical perspective. Our data collection method also resulted in 
unique variables which have not been previously described and provides a basis for 
advanced statistical models which can be used to describe disease presentation and 
duration.  
 Currently, this is the only review at present knowledge which has looked through 
case reports and generated this type of data. Data from the CDC is limited and most of 
the clinical information is abstracted from a single report by Dworkin et.al.34  To our 
knowledge, our sample size represents the largest of its kind and most geographically 
represented as well. In the Dworkin et.al paper used by the CDC, information was 
gathered on only 4 different states, limited to the most north-west part of the United 
States. Given its geographical niche, it is reasonable to infer that this data might be 
limited to B. hermsii infections only which might describe some differences in findings. 





showed differences in clinical presentation based on infection type. Symptom frequency 
found in our review is similar to CDC reported data.18 Specific frequency percentages of 
symptoms vary marginally but the relative frequencies are identical (i.e. the same 
symptoms present the most frequently in our review and previous work, such as 
headaches, myalgia, and chills being reported most often). In our analysis, which 
contained clinical information on 337 patients, B. turicatae infections were found to have 
significantly higher incidences of fever, headache, nausea, emesis, weakness, and more 
symptoms despite being much less representative in our sample. This suggests quite 
possibly that B. turicatae infections clinically manifest differently from B. hermsii 
infections and that treatment and symptom management practices for each disease should 
be approached separately instead of how they are currently treated as one.  
 Profiling this disease is challenging due to the wide array of symptomology and 
clinical presentation. The pathogen was found in individuals without fever, suggesting 
that infections can occur which do not cause fever but still cause other flu-like symptoms. 
Those asymptomatic infections noted in our review were identified in outbreak 
investigations, suggesting that all persons with exposures should be tested for infection. 
While the majority of cases did report fever and flu-like illness described above, 
symptoms were not consistently grouped together between patient populations or within 
the individual patient. Within a single individual, different febrile relapse episodes could 
be accompanied by a multitude of other symptoms and rarely were they consistent. While 
febrile episodes typically lessened in duration after the initial episode, this was not 
always true. At present, this review, nor any other articles have been able to identify 





TBRF, besides relapsing episodes, is fever temperature which averaged over 103 degrees 
Fahrenheit. From data collected it was not possible to determine a statistical relationship 
between the number of febrile relapses and temperature. Because temperature was 
typically recorded for only the first febrile episode, there was not enough data to make 
any inference on whether temperature wanes or increases with repeated febrile relapses. 
The current position on febrile periods typically site three days for any one febrile period 
but it is not clear how this number was determined. In our study, febrile periods were 
usually one or two days, and subsequent relapses usually had shorter febrile periods, but 
this was not always the case. In our study we used relapse data to not only look at the 
expected number of febrile days a patient might experience for any one episode, but we 
looked at how many days total an individual would be expected to experience fever 
during the entire course of the disease. Our analyses found the expected number of febrile 
episodes to be three and expected number of total febrile episodes for both infections’ 
types combined to be six days. This indicates that febrile periods might be shorter than 
previously described but they might also be different depending on infection type. While 
not statistically different, our analysis showed the average number of febrile episodes for 
B. turicatae infections was two days less than its B. hermsii counterpart. Afebrile periods 
have not been previously described but were included in this review to shed light on how 
long the disease can endure. Afebrile periods, which averaged 7 days overall, and were 
higher (albeit not statistically) in B. turicatae infections. One extreme case noted afebrile 
periods accumulating 48 days resulting in relapsing fevers for months. There were 





infections, adding to the complications in characterizing the disease’s clinical 
presentation.  
 Our results indicate that B. turicatae infections are clinically different from B. 
hermsii infections and in many cases are associated with increased morbidity. Incubation 
days for B. turicatae infections were longer, number of febrile episodes higher, and 
reported higher proportions of various symptoms. Some of these differences may be due 
to physicians not being aware that TBRF infections have two different causative agents. 
This could lead to delayed diagnosis and in turn could cause a delay in treatment leading 
to more febrile episodes, febrile days, and afebrile days.  
 TBRF treatment has evolved over the years with the advent of different antibiotics 
but there seems to be little guidance in how these treatments are selected. To analyze 
treatment effectiveness, we ran regressions to see if certain treatments resulted in better 
outcomes. The current position in the medical community indicates that tetracycline is 
the preferred treatment but there is little data to support why that is the case, even so, 
tetracycline was used in our analyses as the referent group for this reason. Our data does 
not support the hypothesis that other antibiotics or treatments, such as penicillin or 
combination therapies might be more effective in reducing the risk of Jarisch – 
Herxheimer reactions compared to tetracycline treatments alone but we note that due to a 
small sample size, our ability to detect such a difference is limited. We cannot, at this 
time, make any statistically sound inference on the association between treatment type 
and risk of Jarisch – Herxheimer reaction. To analyze the number of febrile episodes we 
used a Poisson regression. In this analysis, tetracycline results in lower incidence rate of 





results are not statistically sound but both regressions provide the basis for the type of 
analyses which can be used in the future on larger data sets to infer better and more 
efficient treatment options for TBRF.  
 Consistent with prior assumptions, we found TBRF is primarily found in 
traditionally healthy populations, occurring in summer months when vacationing to 
remote cabins is most likely to occur. Sites which are older, have less regular upkeep, and 
are uninhabited at times during the year present the most likely areas in which risk of 
infection is higher.35 Temperature plays a catalytic role in the epidemiology of this 
disease; hot weather encourages reservoir mammals to venture out of the tick’s habitat 
while simultaneously attracting naïve humans into the habitat. During the fall and winter 
months, rodent species turn to indoor or sheltered habitats to wait out the cold and 
harshness of the outside conditions. Ornthidoros spp. ticks lie in wait to take blood meals 
and ingest infected blood from rodent species which act as reservoirs and harbor the 
Borellia bacteria. It is possible that Borellia hermsii and or Borellia turicate spirochetes 
can be vertically transmitted during birth resulting in some ticks being born as vectors, 
hosting the bacteria in their saliva.36 While rarely obsreced there is alos another route for 
vector infection. Hyperparasitism between O. hermsi ticks has been observed which 
resulted in previously uninfected O. hermsi ticks becoming infected with B. hermsii 
spirochetes after being fed on by infected ticks.37 As the temperature increases during the 
spring in summer, the rodents leave their nests to forage in the more hospitable climate 
while outdoor enthusiasts move indoors to enjoy seasonal respites and become new hosts 
to ticks. These seasonal movements are not just affected by temperature but also 





only 21% of the time. This low number is partly due to the fact that not all sites were 
investigated for tick infestations, but many which were still turned up no ticks. A special 
report published in 2009 by Gaither, et.al provides a possible explanation for this.38 
Gaither posits that tick movements are influenced by which host they are attempting to 
feed on. Their research group originally began looking for ticks where one might assume 
them to be found, in the nests of rodents, but soon found out that they were nowhere to be 
seen. When widening their scope, they found black tar residues which turned out to be 
blood as well as live and dead ticks in the cracks along window, near pictures close to 
windows, crevices of walls, and near sleeping areas. Gaither mentions that finding soft 
shelled ticks in these locations is unusual, so her team hypothesized that the ticks make 
accommodations for host type and were moving within their area to increase the 
likelihood of blood meals when humans were present. This hypothesis is not only 
interesting because it gives researchers a better idea of where to locate these ticks but also 
it shows that these, mostly nidicolous ticks, can become mobile and adapt to their hosts 
making them far more resourceful than previously considered.   
 While most cases occurred in males there is no particular reason noted in this 
review or any other literature source to indicate this is anything more than incidental. It 
might be the case that areas where infection risk is higher might be visited more often by 
males than females but there is no evidence of sex inherently increasing risk of infection. 
Many of our cases took place in boys’ camps, caves, and forest cabins. It might be that 
Ornthidoros spp. ticks inhabit areas frequented more my males compared to females.39 
There is evidence to support this. We spoke to The National Speleological Society which 





also found no evidence to indicate that individuals might be more prone to infection 
based on age, as infection was found in all age groups. Although mostly found in adults 
and children, these groups most likely represent those coming into contact with these 
nesting ticks due to their active lifestyles.  
 TBRF incidence is virtually impossible to measure due to lack of surveillance and 
different reporting practices in 12 states that consider TBRF a notifiable condition. State 
health department websites vary widely in which diseases have publicly available data 
from year to year. TBRF is often left off the infectious disease surveillance reports for 
years at time and there is no information on discerning infection type. The only major 
reviews covering TBRF are an MMWR report published in 2015 with data on 504 cases 
collected from 1990 - 2011 and the aforementioned article by Dworkin, et.al published in 
1998 with information on 182 cases from 1980 – 1995.15,16 While their reviews have 
similar findings to this one, one major difference is noted in respect to the occurrence of 
Jarisch-Herxheimer reactions. Dworkin, et. al reported that Jarisch-Herxheimer reactions 
occurred roughly 50% of the time in their 1998 review with 34 of the 66 cases which had 
data on this outcome included in that review. Our review, which spans published reports 
over a 100 - year span did not note nearly as many cases. There are a couple possible 
solutions to resolve this discrepancy. One possibility is that the published reports did not 
often have access to the complete details of the medical records which record which 
described treatment and reaction. Another might be lack of awareness of the reaction led 
to a lack of recognition when reviewing case files and misconstrued for the disease itself 
instead of a response to treatment. By looking at medical records, Dworkin and his team 





reported due to the patients notes and symptom descriptions after treatment. It is possible 
that disease management today is better than it was when Dworkin was collecting data 
for his review 20 years ago but there is no formal treatment recommendation and despite 
prevailing advice suggesting that tetracycline treatment is the best course for adults and 
unpregnant women, our review noted cases of Jarisch-Herxhemier reactions in response 
to that antibiotic as well as others. Regardless, the sample size from which this statistic 
was derived is probably inflating how often this reaction is actually occurring but the 
observations from both of these studies show why this outcome is of particular interest in 
TBRF treatment.  
 This review highlights a number of reasons why TBRF should be a nationally 
notifiable disease. Firstly, no major published works has summarized the current state of 
the disease in the United States for over a decade. Secondly, the quality of data on the 
topic and access to it are unreliable and leave much to be desired. California’s state health 
department has arguably the best information publicly available on the disease but lacks 
crucial information on treatment, number of relapses, and duration of disease. In other 
states where TBRF is reportable, yearly incidence is not even reported in their 
surveillance reports consistently, sometimes skipping years entirely. This leads to 
inconsistent data, missing data, and a lack of not only public but professional awareness 
which causes the disease to go mistreated and underdiagnosed. Even with standardized 
reporting measures, universal reporting criteria, and increased awareness, this disease 
will be challenging to address due to its multifaceted and unique clinical presentations, 






 TBRF is a traveler’s disease. Most of our cases show that individuals or families 
were vacationing or staying in remote wooded areas when they were infected. TBRF is 
difficult to diagnose on its own but is more likely to be diagnosed in states where the 
disease is endemic because physicians are more likely to look for it. For traveler’s which 
return home to states where TBRF is not normally found and is not a reported disease, a 
correct diagnosis might never be confirmed. The disease will usually run a self-limiting 
course, but improper treatment and management will prolong patient suffering and 
discomfort. To showcase this issue, consider the following evidence which was found in 
during our review. TBRF was identified in travelers from Nebraska, Kansas, Florida, and 
Texas in one report where all travelers had stayed in the same cabin located in the Rocky 
Mountains in Colorado in 1995.40 While TBRF is found frequently in Texas it is not in 
the other states mentioned. Upon returning home, the individuals from Texas were more 
likely to be diagnosed correctly sooner. Without knowing what diseases are endemic in 
certain areas, knowing which area a patient stayed in does little good. In another case 
from 1967, a woman who had visited western states where TBRF is commonly found 
returned to Boston and presented with multiple relapses of fever.41 This was originally 
treated as a viral infection and the patient was discharged from the hospital when her 
fever waned. When her fever recrudesced, she was readmitted and eventually received 
tetracycline treatment until her fever and other symptoms reduced and was discharged 
again. Had her doctor been aware of TBRF and the areas which it is endemic he or she 
might have diagnosed TBRF sooner and saved the patient a return to the hospital.  
This scenario where an outdoor enthusiast travels to an endemic area, becomes infected 





to their home state, and has an extended course of disease due to a lack of physician 
knowledge is not conjecture but shown to be likely common. The current state of 
knowledge on the disease is such that physicians in non-endemic regions of the United 
States are more likely to allow for greater periods of patient distress and continue to 
contribute to underreporting of the disease.  
 TBRF is rarely fatal and over the course of a century, only two published case 
reports resulted in mortality. The first, an elderly individual close to 70 years of age had a 
heart attack while experiencing a febrile episode and subsequently died.42 Her symptom 
profile reported one of the highest fevers collected in our review (105 degrees 
Fahrenheit) and she also experienced hepatic enlargement which was one of the more 
advanced, yet less common, symptoms. The second individual, a newborn infant, died 
quickly after birth after acquiring a TBRF infection via transplacental means from the 
mother.43 The only symptom reported were seizures and a low-grade fever before the 
infant was found unresponsive. Both fatal cases had been identified as having a B. 
hermsei infection. TBRF mortality is likely rare due to TBRF infections typically 
occurring in younger, more robust individuals in good health. Despite the low mortality 
rate, TBRF should still be considered especially dangerous to infant and elderly 
populations and appropriate treatment is crucial to prevent death. Additionally, a higher 
number of clinically advanced cases were seen. Meningitis cases, hepatosplenomegaly, 
tachycardia, dyspnea and tachypnea and even jaundice. These are associated with much 
worse outcomes and can be risk factors for disease later in life.  
 While not communicable from person to person, the disease has the potential to 





incidence. Three of our papers included in this review highlight this potential. On two 
separate occasions, once in 1973, and again in 1990, outbreaks of TBRF occurred at the 
Grand Canyon National Park in Arizona. In the first instance, 10 individuals were 
infected between June and July of 1973. In almost the exact same location 17 years later 
another 17 individuals were positively diagnosed with TBRF indicating that there are 
hotspots for the tick vectors and their reservoirs where the pathogen maintains a stable 
presence in the area. As recently as 2014, an outbreak occurred at an outdoor education 
camp in Arizona where six confirmed cases and five probable cases of TBRF were 
identified. The camps were often uninhabited save for the warmer months when campers 
took up residence in older cabins.44–46  These examples are likely to become more 
commonplace as accommodations and dwellings age and deteriorate, constructing 
hospitable vector and mammalian reservoir habitats. The climate might begin to play 
more of a factor as well. With warmer temperatures due to global warming, spring and 
summer seasons are likely to see longer durations which will increase the window in 
which infections are most likely to occur. Warmer climate might influence tick 
movements as well. Although they are nesting ticks, the Ornthidoros species riding on 
the backs of rodents or birds might find themselves in new areas if their hosts are able to 
cover more ground for longer periods of time.47 If the ecological niche of these ticks 
expands then a rise in incidence would be expected. Having a national reporting 
recommendation would result in increased awareness for states which are currently not 
experiencing TBRF infections but might begin to develop some. This would lead to 
quicker recognition and better treatment plans for patients. The severity of the disease, 





The reoccurrence rate derived from the secondary analysis was 75%, meaning that 
patients are very likely to experience more than one febrile episode with an unpredictable 
accompaniment of debilitating symptoms as well as a high fever. This can hospitalize 
patients for days, keeping them from work, accumulating considerable personal and 
hospital economic burdens.   
 This review summarizes a large period of time on published data and gives an 
idea as to the scope of not only the disease itself but the difficulty in studying and treating 
it. The major limitations of this study are the relatively small sample size, missing data, 
and data quality. Although, this being a review, is a reflection of the quality and quantity 
of published data available and a reflection of the overall limitations in studying the 
disease. This review, while expansive in both years, as well as the amount of information 
included does have a number of limitations. The first of which is the data collection 
process. While other reviews had requested state specific data from health departments 
and accompanying medical records, our review was conducted using only published 
literature. The accuracy of our data is dependent on the various methodologies utilized in 
the published reports we used to construct our data set and often these reports shared 
varying degrees of information, some detailed and ordinal, others less so. In places where 
exact data was not available, best estimates were used for analysis. Some of the years 
listed for reviews gave a range but did not associate their cases with precise years, in this 
instance we chose to take the midpoint of the range as the year of incidence. Overlapping 
cases is a possible issue. While we diligently reviewed the papers chosen so as not to 
include duplicate data there is still the possibility that some of these cases might have 






it is difficult to tell if those cases overlap with any on other reports on cases in those areas 
within those years.  
 Generalizability is another possible issue. Due to the unique methodology 
presented here, making comparisons between previous works must be taken with some 
considerations in mind on how data was collected in those papers vs. this one. 
Comparisons within this paper should also be thought of in the same light given the 
added criteria for inclusion in the secondary analysis. This difference can help explain 
some possible notable discrepancies in the data presented here.  
 Despite its limitations, we note that this review has a number of strengths. This is 
the only review, to our knowledge, that has reported on TBRF and analyzed differences 
in clinical presentation and prognosis by infection type. Another strength of this study is 
its sample size and geographic range, including data on 14 states. This review also 
highlights trends and updates the medical and epidemiological community with the 
largest study on the topic in many years. This study was able to show that there are 
differences in clinical presentation of this disease based on infection type and these 
differences are worth further exploring to standardize treatment protocols and diagnosis, 
lower morbidity and mortality, and help preventions efforts by targeting endemic areas 
and hotspots as well as increase the public awareness of the disease. With increased 
awareness and standardized reporting measures, physicians and public health 
professionals can more readily identify a relapsing fever infection and treat it. Increased 
treatment not only leads to better health outcomes and reduced morbidity for patients but 
also increases the amount of data available on treatment which can improve treatment 





 This review can be seen as a template for the type of information and reporting 
which would be useful in the NNDSS. Data on infection type is crucial to understanding 
how and where the pathogen spreads and how this results in different clinical 
presentations. Furthermore, understanding which treatments work best requires precise 
data on which antibiotics were used, their dosage, and treatment course with an emphasis 
on lowering the number of relapses and incidence of Jarisch-Herxheimer reactions. In 
addition, modeling data can be improved by inclusion of more covariates. In this review, 
data on only sex and age was available but race, body mass index, socioeconomic status, 
etc. might be important for developing reliable models. In conclusion, TBRF should be a 
nationally notifiable disease because it is vastly underreported, lacks awareness in the 
medical community, especially in non-endemic states, is reported infrequently and 
inconsistently which results in poor data pertaining to the disease and its pathogen, and 
because best treatment practices which limit morbidity and other unfavorable outcomes is 
impossible to determine with the current data available. An inclusion on the list of 
nationally notifiable conditions will push TBRF to the forefront of clinician concerns, 
create better data quality on this disease, and limit future infections and outbreaks while 
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